The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 83, Issue 4-6, 2010, Pages 193-201

  Lim, Siew Na ^a,b   Huang, Wenlong ^a   Hall, Jodie C E ^a   Ward, Rachael E ^a   Priestley, John V ^a   Michael Titus, Adina T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Eicosapentaenoic acid; Neuroprotection; Omega 3 fatty acids; Spinal cord injury

Indexed keywords

ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BLOOD BRAIN BARRIER; CELL LABELING; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; IMMUNOCYTOCHEMISTRY; LOCOMOTION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SPINAL CORD COMPRESSION; TREATMENT OUTCOME;

ANIMALS; AXONS; EICOSAPENTAENOIC ACID; FEMALE; MOTOR ACTIVITY; NEURONS; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD COMPRESSION; SPINAL CORD INJURIES;

ANIMALIA; RATTUS;

EID: 78649418163     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.08.003     Document Type: Article

References (32)

1. Arita M., Ohira T., Sun Y.P., Elangovan S., Chiang N., Serhan C.N. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 2007, 178:3912-3917.
2. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994, 12:141-179.
3. Basso D.M., Beattie M.S., Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 1996, 139:244-256.
4. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 1998, 18:3251-3260.
5. Blight A.R. Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling. Neuroscience 1983, 10:521-543.
6. Calder P.C. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009, 91:791-795.
7. Dyall S.C., Michael G.J., Whelpton R., Scott A.G., Michael-Titus A.T. Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiol. Aging 2007, 28:424-439.
8. Eidelberg E., Story J.L., Walden J.G., Meyer B.L. Anatomical correlates of return of locomotor function after partial spinal cord lesions in cats. Exp. Brain Res. 1981, 42:81-88.
9. Fehlings M.G., Tator C.H. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 1995, 132:220-228.
10. Genovese T., Esposito E., Mazzon E., Crisafulli C., Paterniti I., Di Paola R., Galuppo M., Bramanti P., Cuzzocrea S. PPAR-alpha modulate the anti-inflammatory effect of glucocorticoids in the secondary damage in experimental spinal cord trauma. Pharmacol. Res. 2009, 59:338-350.
11. Genovese T., Esposito E., Mazzon E., Di Paola R., Muia C., Meli R., Bramanti P., Cuzzocrea S. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury. Shock 2008, 30:142-152.
12. J.C.E. Hall, J.V. Priestley, V.H. Perry, A.T. Michael-Titus, Effect of docosahexaenoic acid and eicosapentaenoic acid on the early inflammatory response following compression spinal cord injury in the rat, submitted.
13. Huang W.L., George K.J., Ibba V., Liu M.C., Averill S., Quartu M., Hamlyn P.J., Priestley J.V. The characteristics of neuronal injury in a static compression model of spinal cord injury in adult rats. Eur. J. Neurosci. 2007, 25:362-372.
14. Huang W.L., King V.R., Curran O.E., Dyall S.C., Ward R.E., Lal N., Priestley J.V., Michael-Titus A.T. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007, 130:3004-3019.
15. Kakulas B.A. The applied neuropathology of human spinal cord injury. Spinal Cord 1999, 37:79-88.
16. King V.R., Huang W.L., Dyall S.C., Curran O.E., Priestley J.V., Michael-Titus A.T. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 2006, 26:4672-4680.
17. Kwon B.K., Tetzlaff W., Grauer J.N., Beiner J., Vaccaro A.R. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 2004, 4:451-464.
18. Lang-Lazdunski L., Blondeau N., Jarretou G., Lazdunski M., Heurteaux C. Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J. Vasc. Surg. 2003, 38:564-575.
19. Lo C.J., Chiu K.C., Fu M., Lo R., Helton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J. Surg. Res. 1999, 82:216-221.
20. Mayser P., Mayer K., Mahloudjian M., Benzing S., Kramer H.J., Schill W.B., Seeger W., Grimminger F. A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis. JPEN J. Parenter. Enteral. Nutr. 2002, 26:151-158.
21. Murata M., Kaji H., Takahashi Y., Iida K., Mizuno I., Okimura Y., Abe H., Chihara K. Stimulation by eicosapentaenoic acids of leptin mRNA expression and its secretion in mouse 3T3-L1 adipocytes in vitro. Biochem. Biophys. Res. Commun. 2000, 270:343-348.
22. Murphy E.J., Behrmann D., Bates C.M., Horrocks L.A. Lipid alterations following impact spinal cord injury in the rat. Mol. Chem. Neuropathol. 1994, 23:13-26.
23. Onifer S.M., Rabchevsky A.G., Scheff S.W. Rat models of traumatic spinal cord injury to assess motor recovery. ILAR J. 2007, 48:385-395.
24. Ouellet M., Emond V., Chen C.T., Julien C., Bourasset F., Oddo S., LaFerla F., Bazinet R.P., Calon F. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Neurochem. Int. 2009, 55:476-482.
25. I. Paterniti, E. Esposito, E. Mazzon, M. Galuppo, R. di Paola, P. Bramanti, A. Kapoor, C. Thiemermann, S. Cuzzocrea, Evidence for the role of PPAR-{beta}/{delta} the development of spinal cord injury, J. Pharmacol. Exp. Ther. (2010).
26. Ramer L.M., Ramer M.S., Steeves J.D. Setting the stage for functional repair of spinal cord injuries: a cast of thousands. Spinal Cord 2005, 43:134-161.
27. Serhan C.N., Arita M., Hong S., Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004, 39:1125-1132.
28. Sierra S., Lara-Villoslada F., Comalada M., Olivares M., Xaus J. Dietary eicosapentaenoic acid and docosahexaenoic acid equally incorporate as decosahexaenoic acid but differ in inflammatory effects. Nutrition 2008, 24:245-254.
29. Taepavarapruk P., Song C. Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment. J. Neurochem. 2010, 112:1054-1064.
30. Uauy R., Hoffman D.R., Mena P., Llanos A., Birch E.E. Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials. J. Pediatr. 2003, 143:S17-25.
31. Yoneda H., Shirao S., Kurokawa T., Fujisawa H., Kato S., Suzuki M. Does eicosapentaenoic acid (EPA) inhibit cerebral vasospasm in patients after aneurysmal subarachnoid hemorrhage?. Acta Neurol. Scand. 2008, 118:54-59.
32. Zhao Y., Joshi-Barve S., Barve S., Chen L.H. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J. Am. Coll. Nutr. 2004, 23:71-78.